U.S. Food and Drug Administration to Add Warning Label to Popular Flu Drugs

After 25 deaths in children while taking Tamiflu and an unusual number of occurrences of neurological disorders in children taking Relenza, a panel of pediatic experts will meet on November 27 to review the safety profile of the two most popular flu drugs. There is no evidence that directly links the drugs to the events but the unusual number of deaths and psychotic episodes including delirium and hallucinations has prompted the review.

The FDA has reviewed 596 cases of psychiatric cases linked to Tamilflu and 115 cases of psychiatric cases linked to Relenza.

Filed under Uncategorized |